Statistics for In Vitro Evaluation of Novel Reverse Transcriptase Inhibitors TAF (Tenofovir Alafenamide) and OBP-601 (2,3-didehydro-3-deoxy-4-ethynylthymidine) Against Multi-Drug Resistant Primary Isolates of HIV-2
Total visits
| views | |
|---|---|
| In Vitro Evaluation of Novel Reverse Transcriptase Inhibitors TAF (Tenofovir Alafenamide) and OBP-601 (2,3-didehydro-3-deoxy-4-ethynylthymidine) Against Multi-Drug Resistant Primary Isolates of HIV-2 | 45 |
Total visits per month
| views | |
|---|---|
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
| May 2025 | 0 |
| June 2025 | 0 |
| July 2025 | 0 |
File Visits
| views | |
|---|---|
| Antivriral Res 2019_161_85.pdf(legacy) | 152 |
| Antivriral Res 2019_161_85.pdf | 10 |
Top country views
| views | |
|---|---|
| Portugal | 17 |
| United States | 15 |
| China | 9 |
| Brazil | 1 |
| Germany | 1 |
| France | 1 |